Cetuximab plus TPF feasible and active as induction therapy: Commentary

  • Marshall R. Posner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)52
Number of pages1
JournalOncology Report
Issue numberFALL
StatePublished - Sep 2008

Cite this